| [1] | ILTER A,OREM C,YUCESAN FB,et al.Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease[J].Int J Clin Exp Med,2015,8(6):9394. |
| [2] | DOMBROWSKI SU,FORD GA,MORGENSTERN LB,et al.Differences between US and UK adults in stroke preparedness:evidence from parallel population-based community surveys[J].Stroke,2015,46(11):3220. |
| [3] | TSIVGOULIS G,PSALTOPOULOU T,WADLEY VG,et al.Wadley,adherence to a Mediterranean diet and prediction of incident stroke[J].Stroke,2015,46(3):780. |
| [4] | LANSBERG MG,O'DONNELL MJ,KHATRI P,et al.Antithrombotic and thrombolytic therapy for ischemic stroke:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141(Suppl 2):e601S. |
| [5] | MESCHIA JF,BUSHNELL C,BODEN-ALBALA B,et al.Guidelines for the primary prevention of stroke:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2014,45(12):3754. |
| [6] | HOWARD G,BANACH M,CUSHMAN M,et al.Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension[J].Stroke,2015,46(6):1595. |
| [7] | HOWARD VJ,WOOLSON RF,EGAN BM,et al.Prevalence of hypertension by duration and age at exposure to the stroke belt[J].J Am Soc Hypertens,2010,4(1):32. |
| [8] | HOWARD VJ,TANNER RM,ANDERSON A,et al.Apparent treatment-resistant hypertension among individuals with history of stroke or transient ischemic attack[J].Am J Med,2015,128(7):707. |
| [9] | IRVIN MR,BOOTH JN 3rd,SHIMBO D,et al.Apparent treatment-resistant hypertension and risk for stroke,coronary heart disease,and all-cause mortality[J].J Am Soc Hypertens,2014,8(6):405. |
| [10] | WILLEY JZ,BOEHME AK,CASTAGNA F,et al.Hypertension and stroke in patients with left ventricular assist devices(LVADS)[J].Curr Hypertens Rep,2016,18(2):12. |